Constance Care (WAR:CCR) ROCE %: -0.38% (As of Mar. 2026)


WAR:CCR Constance Care SA WAR:CCR
33 GF Score
Price zł6.00
GF Value zł0.15
Valuation Significantly Overvalued
View Full Analysis

What is Constance Care ROCE %?

Constance Care WAR:CCR 33 ROCE % is -0.38% as of Mar. 2026. GuruFocus rates WAR:CCR with a GF Score™ of 33/100 and a GF Value™ of zł0.15 (Significantly Overvalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Constance Care's annualized ROCE % for the quarter that ended in Mar. 2026 was -0.38%.

Constance Care  (WAR:CCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Constance Care ROCE % Related Terms

Constance Care ROCE % Historical Data

* Premium members only.

The historical data trend for Constance Care's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Constance Care ROCE % Chart

Constance Care Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 5.11 4.18 0.24 -30.86 -0.36

Constance Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 -0.46 -0.36 -0.04 -0.38
WAR:CCR
33GF Score
Constance Care SA WAR:CCR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Constance Care ROCE % Calculation

Constance Care's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-0.036/( ( (15.691 - 5.246) + (12.648 - 3.052) )/ 2 )
=-0.036/( (10.445+9.596)/ 2 )
=-0.036/10.0205
=-0.36 %

Constance Care's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-0.036/( ( (12.648 - 3.052) + (12.587 - 3.12) )/ 2 )
=-0.036/( ( 9.596 + 9.467 )/ 2 )
=-0.036/9.5315
=-0.38 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -0.38% mean?
Constance Care (WAR:CCR) has a ROCE % of -0.38% as of Mar. 2026.
Is Constance Care's ROCE % too high?
Constance Care's current ROCE % is -0.38%. Overall, Constance Care has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constance Care's ROCE % compare to HCA and UHS?
Constance Care's ROCE % of -0.38% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Constance Care's current ROCE % is -0.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constance Care stock overvalued right now?
Based on GuruFocus' analysis, Constance Care (WAR:CCR) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.15, compared to a current price of zł6.00 — trading 3900% above its estimated fair value. The current ROCE % is -0.38%. Constance Care's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Constance Care (WAR:CCR), the current ROCE % is -0.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Constance Care (WAR:CCR) Overvalued in 2026?

Based on GuruFocus' analysis, Constance Care stock appears to be overvalued. The current stock price of zł6.00 is trading 3900% above its estimated GF Value™ of zł0.15. GuruFocus considers Constance Care to be Significantly Overvalued.

Key valuation signals for WAR:CCR:

  • ROCE %: -0.38%
  • GF Value™: zł0.15 vs. price of zł6.00 (3900% above fair value)
  • GF Score™: 33/100

No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Constance Care Business Description

Address ul. Dzialkowa 125, Kierszek, POL, 05-500
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
33GF Score

Get the complete analysis for WAR:CCR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł6.00
Price
zł0.15
GF Value